Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-09
2006-05-09
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S466000, C549S467000
Reexamination Certificate
active
07041700
ABSTRACT:
This invention relates to benzopyran derivatives of the formula (1) or the formula (2) wherein R1and R2represent independently of each other hydrogen atom or C1-6alkyl group, R3represents hydroxyl group or C1-6alkylcarbonyloxy group, R4represents hydrogen atom or C1-6alkyl group, R5represents C1-6alkyl group substituted with C6-14aryl group or heteroaryl group, R6represents C1-6alkyl group, C1-6alkoxy group, halogen atom, nitro group, C(O)NH2, C(O)NHR8or C(O)NR8R9, or pharmaceutically acceptable salts thereof. These compounds are useful as an antiarrhythmic agent
REFERENCES:
patent: 5095016 (1992-03-01), Ohtuka et al.
patent: 5097037 (1992-03-01), Matsumoto et al.
patent: 5276168 (1994-01-01), Atwal
patent: 5420314 (1995-05-01), Katsuki et al.
patent: 5466817 (1995-11-01), Atwal
patent: 5624954 (1997-04-01), Evans et al.
patent: 5679706 (1997-10-01), D'Alonzo et al.
patent: 6150356 (2000-11-01), Lloyd et al.
patent: 0 409 165 (1991-01-01), None
patent: 0 462 761 (1991-12-01), None
patent: 0 535 377 (1993-04-01), None
patent: A-52-91866 (1977-08-01), None
patent: A-56-57785 (1981-05-01), None
patent: A-56-57786 (1981-05-01), None
patent: A-58-67683 (1983-04-01), None
patent: A-58-188880 (1983-11-01), None
patent: A-62-273972 (1987-11-01), None
patent: A-2-141 (1990-01-01), None
patent: A-3-141286 (1991-06-01), None
patent: A-5-301878 (1993-11-01), None
patent: A-5-507645 (1993-11-01), None
patent: A-7-285983 (1995-10-01), None
patent: A-10-87650 (1998-04-01), None
patent: A-11-209366 (1999-08-01), None
patent: A-2001-151767 (2001-06-01), None
patent: WO 95/34547 (1995-12-01), None
patent: WO 00/12077 (2000-03-01), None
Lloyd, J. et al Preparation of benzopyran, tetrahydroquinoline, pyro[2,3-b]pyridine, and indane derivatives as potassium channel inhibitors (2000) CA 132:207763.
Hiessboeck, R et al ‘Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines’ (1999) CA 131:87799.
Rovnyak, GC et al ‘Preparation of 4-(arylamino)benzopyrans and analogs as cardiovascular agents’ (1998) CA 130:13916.
Ding CZ et al ‘Syntheis of 4-(N-alkyl-N-heteroarylamino)-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-carbonitrile derivatives via an unusual 1,4-oxygen to nitrogen heteroaryl migration’ (1996) CA 125:195558.
Vong AKK et al Preparationof 4-benzoylamino-3,4-dihydro-2H-benzopyran-3-ol derivatives and analogs as therapeutic agent (1996) CA 124:260843.
Blackburn, TP et al ‘Stereochemical differentiation of anticonvulsant and antihyperstnnsive effects in 4-(fluorobenzoylamino)benzopyrans’ (1995) CA 124:86760.
Evans, JM et al ‘Electron impact behavior of trans-4-benzolyamino-2H-1-benzopyran-3-ols: evidence for an oxygen migration with loss of a benzopyrane’ (1995) 123:198143.
Conners et al., “The Synthesis and Potassium Channel Blocking Activity of Some (4-Methanesullfonamidophenoxy)propanolamines as POtential Class III Antiarrhythmic Agents,”J. Med. Chem, vol. 34, No. 5, pp. 1570-1577, 1991.
Nicolau et al., “Natural Product-like Combinatorial Libraries based on Privileged Structures 3. The ‘Libraries from Libraries’ Principle for Diversity Enhancement of Benzopyran Libraries,”J. Am. Chem. Soc., vol. 122, No. 41, pp. 9968-9976, 2000.
Evans et al., “Synthesis and Antihypertensive Activity of 6,7-Disubstituted trans-4-Amino-3,4-digydro-2,2-dimethyl-2H-1-benzopyran-3-ols,”J. Med. Chem., vol. 27, No. 9, pp. 1127-1131, 1984.
Ashwood et al., “Synthesis and Antihypertensive Activity of 4-(Cyclic amido)-2H-1-benzopyrans,”J. Med. Chem., vol. 29, No. 11, pp. 2194-2201, 1986.
North et al., Synthesis of 6-Cyano-2,2-dimethyl-2H-1-benzopyran and other Substituted 2,2-dimethyl-2H-1-benzopyran,J. Org. Chem., vol. 60, No. 11, pp. 3397-3400, 1995.
Bell et al., “Copper(I) Iodide: A catalyst for the Improved Synthesis of Aryl Propargyl Ethers,”Synthesis, pp. 707-712, 1995.
Ohara Yoshio
Ohrai Kazuhiko
Shigeta Yukihiro
Tsukagoshi Toru
Yamashita Toru
Nissan Chemical Industries Ltd.
Oliff & Berridg,e PLC
Owens Amelia A.
LandOfFree
Substituted benzopyran derivatives against arrhythmia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzopyran derivatives against arrhythmia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzopyran derivatives against arrhythmia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3535083